Literature DB >> 1549801

Gastric lymphoma treatment. Medical versus surgical.

R C Frazee1, J Roberts.   

Abstract

The treatment of gastric lymphoma is an area of ongoing controversy. Surgical resection has been the standard therapy. Recent advances, however, have been developed in other treatment modalities. A comparison of treatment options is presented.

Entities:  

Mesh：

Year:  1992        PMID： 1549801     DOI： 10.1016/s0039-6109(16)45687-2

Source DB:  PubMed          Journal:  Surg Clin North Am        ISSN： 0039-6109            Impact factor:   2.741


  4 in total

1.  Molecular markers (PECAM-1, ICAM-3, HLA-DR) determine prognosis in primary non-Hodgkin's gastric lymphoma patients.

Authors:  Alexander Darom; Ilias P Gomatos; Emmanuel Leandros; Emmu Chatzigianni; Dimitris Panousopoulos; Manousos M Konstadoulakis; George Androulakis
Journal:  World J Gastroenterol       Date:  2006-03-28       Impact factor: 5.742

2.  Long-term follow-up after curative surgery for early gastric lymphoma.

Authors:  D L Bartlett; M S Karpeh; D A Filippa; M F Brennan
Journal:  Ann Surg       Date:  1996-01       Impact factor: 12.969

3.  Detection of BCL2-IGH rearrangement on paraffin-embedded tissue sections obtained from a small submucosal tumor of the rectum in a patient with recurrent follicular lymphoma.

Authors:  Naohisa Yoshida; Kenichi Nomura; Yosuke Matsumoto; Kazuhiro Nishida; Naoki Wakabayashi; Hideyuki Konishi; Shoji Mitsufuji; Keisho Kataoka; Takeshi Okanoue; Masafumi Taniwaki
Journal:  World J Gastroenterol       Date:  2004-09-01       Impact factor: 5.742

4.  Primary non-hodgkin lymphoma of the stomach: clinicopathological characteristics and prognostic factors in Iranian patients.

Authors:  Sare Hosseini; Parvaneh Dehghan
Journal:  Iran J Cancer Prev       Date:  2014
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.